Milestone Scientific Commences Sales of CompuFlo® Epidural / CathCheck™ Verification System Disposables to a Premier Northeast Hospital
11 April 2022 - 10:30PM
Milestone Scientific Inc.
(NYSE:MLSS), a leading developer of computerized
drug delivery instruments, that provide painless and precise
injections, today reported that, following a successful trial and
evaluation, it has commenced sales of its CompuFlo® Epidural and
CathCheck™ Verification System disposables to a leading northeast
medical center. The hospital has been designated as one of the
World’s Best Hospitals-USA by Newsweek for the fourth consecutive
year.
“We are honored to announce adoption of our CompuFlo Epidural
and CathCheck Verification System by another leading medical
center,” commented Arjan Haverhals, CEO of Milestone Scientific.
“This approval follows a thorough trial and evaluation, which
further validates the safety and efficacy of our technology. As a
teaching hospital, our tools provide residents, fellows and even
seasoned physicians greater accuracy through real-time verification
of epidural needle placement, as well as subsequent monitoring of
catheter placement. The addition of this hospital continues to
expand our nationwide footprint in the labor and delivery
market.”
“Ultimately, our goal is to enable health care providers to get
better outcomes at a lower cost. We plan to achieve this by
supplying a proven technology in anesthesia care through our
CompuFlo Epidural instrument and disposables,” Haverhals
continues.
The clinical and safety benefits of the CompuFlo Epidural and
CathCheck Verification Systems are backed by extensive published
clinical data demonstrating significant reductions in epidural
punctures, as well as complication rates, and contribute to a
significant savings of time on the part of anesthesiologists.
The CompuFlo Epidural System has the potential to significantly
reduce costs associated with morbidity, providing a direct economic
benefit to healthcare institutions. Similarly, the CathCheck
Verification System technology has the potential to transform the
monitoring of catheter placement following an epidural procedure by
confirming the placement of a catheter within two minutes, versus
the 20 to 40 minutes using conventional methods.
About Milestone Scientific
Inc.Milestone Scientific Inc. (MLSS), a technology focused
medical research and development company that patents, designs and
develops innovative injection technologies and instruments for
medical, dental and cosmetic applications. Milestone Scientific’s
computer-controlled systems are designed to make injections
precise, efficient and increase the overall patient comfort and
safety. Their proprietary DPS Dynamic Pressure Sensing Technology®
instruments is the platform to advance the development of
next-generation devices, regulating flow rate and monitoring
pressure from the tip of the needle, through platform extensions of
subcutaneous drug delivery, including local anesthetic. To learn
more, view the MLSS brand video or visit
milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking
statements regarding the timing and financial impact of Milestone's
ability to implement its business plan, expected revenues, timing
of regulatory approvals and future success. These statements
involve a number of risks and uncertainties and are based on
assumptions involving judgments with respect to future economic,
competitive and market conditions, future business decisions and
regulatory developments, all of which are difficult or impossible
to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual
results to differ materially from those indicated by the
forward-looking statements are general economic conditions, failure
to achieve expected revenue growth, changes in our operating
expenses, adverse patent rulings, FDA or legal developments,
competitive pressures, changes in customer and market requirements
and standards, and the risk factors detailed from time to time in
Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report
for the year ended December 31, 2020. The forward-looking
statements in this press release are based upon management's
reasonable belief as of the date hereof. Milestone undertakes no
obligation to revise or update publicly any forward-looking
statements for any reason.
Contact: David Waldman or
Natalya RudmanCrescendo Communications, LLCEmail:
mlss@crescendo-ir.comTel: 212-671-1020
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Apr 2024 to May 2024
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From May 2023 to May 2024